• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Dicarboxylic acids and derivatives

Recent Advances in the Application of 3,3-Difluorodihydrofuran-2,5-dione (CAS: 79802-73-6) in Chemical Biology and Pharmaceutical Research

3,3-Difluorodihydrofuran-2,5-dione (CAS: 79802-73-6) is a fluorinated heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its unique difluorinated structure, serves as a valuable building block in the synthesis of bioactive molecules and functional materials. Recent studies have explored its potential in drug discovery, medicinal chemistry, and materials science, highlighting its role as a key intermediate in the development of novel therapeutics and advanced materials.

One of the most notable applications of 3,3-Difluorodihydrofuran-2,5-dione is its use in the synthesis of fluorinated analogs of biologically active compounds. Fluorination is a common strategy in medicinal chemistry to enhance the metabolic stability, bioavailability, and binding affinity of drug candidates. Researchers have successfully incorporated this compound into the design of fluorinated inhibitors targeting enzymes such as kinases and proteases, which are implicated in various diseases, including cancer and neurodegenerative disorders. The difluorinated moiety of the compound contributes to the improved pharmacokinetic properties of these inhibitors, making them promising candidates for further development.

In addition to its role in drug discovery, 3,3-Difluorodihydrofuran-2,5-dione has been investigated for its utility in materials science. Its ability to participate in cycloaddition reactions and other transformations makes it a valuable precursor for the synthesis of fluorinated polymers and functional materials. These materials exhibit enhanced thermal stability, chemical resistance, and unique electronic properties, making them suitable for applications in electronics, coatings, and biomedical devices. Recent advancements in synthetic methodologies have further expanded the scope of its applications, enabling the precise control of material properties at the molecular level.

The mechanistic insights into the reactivity of 3,3-Difluorodihydrofuran-2,5-dione have also been a focus of recent research. Studies employing computational chemistry and spectroscopic techniques have elucidated the electronic and steric effects of the difluorinated group on its reactivity. These findings have provided a deeper understanding of its behavior in various chemical transformations, facilitating the rational design of new synthetic routes and functional materials. Furthermore, the compound's compatibility with green chemistry principles, such as the use of catalytic processes and renewable solvents, has been explored, aligning with the growing emphasis on sustainable chemical practices.

Despite the progress made, challenges remain in the large-scale synthesis and application of 3,3-Difluorodihydrofuran-2,5-dione. Issues such as regioselectivity in reactions and the need for optimized purification methods are areas of ongoing research. Collaborative efforts between academia and industry are expected to address these challenges, paving the way for broader utilization of this compound in pharmaceutical and material science applications. Future research directions may include the development of novel catalytic systems and the exploration of its potential in emerging fields such as bioorthogonal chemistry and targeted drug delivery.

In conclusion, 3,3-Difluorodihydrofuran-2,5-dione (CAS: 79802-73-6) represents a versatile and promising compound in the realm of chemical biology and pharmaceutical research. Its unique structural features and reactivity profile have enabled its use in diverse applications, from drug discovery to advanced materials. Continued research and innovation in this area hold the potential to unlock new opportunities and address unmet needs in the field. This research brief underscores the importance of this compound and highlights the latest advancements in its application, providing valuable insights for researchers and industry professionals alike.

• 1000339-45-6(Butyl 2,2-difluorobutanoate)
• 699-30-9(Tetrafluorosuccinic anhydride)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)